Decoy Therapeutics
Signal active
Organization
Contact Information
Overview
Decoy Therapeutics is a preclinical stage biotech company building a pandemic preparedness drug development platform using AI design of peptide ‘decoys’ that directly interfere with viral replication machinery.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2020
Employees
1-10
Headquarters locations
Cambridge, Massachusetts, United States, North America
Social
Profile Resume
Decoy Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $3.0M in funding across 12 round(s). With a team of 1-10 employees, Decoy Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Decoy Therapeutics, raised $250.0K. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$250.0K
Details
0
Decoy Therapeutics has raised a total of $250.0K in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Decoy Therapeutics is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Mike Kennealy | - | FUNDING ROUND - Mike Kennealy | 250.0K |
| Michael Heffernan | - | FUNDING ROUND - Michael Heffernan | 250.0K |
| Decoy Therapeutics | - | FUNDING ROUND - Decoy Therapeutics | 250.0K |
| Massachusetts Life Sciences Center | - | FUNDING ROUND - Massachusetts Life Sciences Center | 250.0K |